Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 26, 2014 - Issue 9
222
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study

, , , , , , , , & show all
Pages 1127-1135 | Received 30 Sep 2013, Accepted 07 Jan 2014, Published online: 10 Feb 2014

References

  • Bakeera-Kitaka, S., Conesa-Botella, A., Dhabangi, A., Maganda, A., Kekitiinwa, A., Colebunders, R., & Boulware, D. R. (2011). Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. The International Journal of Tuberculosis and Lung Disease, 15, 1082–1086. doi:10.5588/ijtld.10.0538
  • Bonnet, M. B., Pinoges, L. P., Varaine, F. V., Oberhauser, B. O., O'Brien, D. O., Kebede, Y. K., … Ferradini, L. F.. (2006). Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden. AIDS, 20, 1275–1279. doi:10.1097/01.aids.0000232235.26630.ee
  • Braitstein, P., Nyandiko, W., Vreeman, R., Wools-Kaloustian, K., Sang, E., Musick, B., … Carter, E. J. (2009). The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment. The Pediatric Infectious Disease Journal, 28, 626–632. doi:10.1097/INF.0b013e31819665c5
  • Chamie, G., Luetkemeyer, A., Charlebois, E., & Havlir, D. V. (2010). Tuberculosis as part of the natural history of HIV infection in developing countries. Clinical Infectious Diseases, 50(Suppl. 3), S245–S254. doi:10.1086/651498
  • Dheda, K., Lampe, F. C., Johnson, M. A., & Lipman, M. C. (2004). Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Journal of Infectious Diseases, 190, 1670–1676. doi:10.1086/424676
  • Edmonds, A., Lusiama, J., Napravnik, S., Kitetele, F., Van, R. A., & Behets, F. (2009). Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. International Journal of Epidemiology, 38, 1612–1621. doi:10.1093/ije/dyp208
  • Gao, L., Zhou, F., Li, X., & Jin, Q. (2010). HIV/TB co-infection in mainland China: A meta-analysis. PLoS One, 5, e10736. doi:10.1371/journal.pone.0010736
  • Girardi, E., Sabin, C. A., d'Arminio Monforte, A., Hogg, B., Phillips, A. N., Gill, M. J., … Sterne, A. C. J. (2005). Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clinical Infectious Diseases, 41, 1772–1782. doi:10.1086/498315
  • HIV-CAUSAL Collaboration. (2012). Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clinical Infectious Diseases, 54, 1364–1372. doi:10.1093/cid/cis203
  • Kampmann, B., Tena-Coki, G. N., Nicol, M. P., Levin, M., & Eley, B. (2006). Reconstitution of antimycobacterial immune responses in HIV-infected children receiving HAART. AIDS, 20, 1011–1018. doi:10.1097/01.aids.0000222073.45372.ce
  • Lawn, S. D., Harries A. D., Williams, B. G., Chaisson, R. E., Losina, E., De Cock, K. M., & Wood, R. (2011). Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? The International Journal of Tuberculosis and Lung Disease, 15, 571–581. doi:10.5588/ijtld.10.0483
  • Liang, L., & Hongjin, D. (2004). The epidemic of children tuberculosis in China. Zhonghua Yi Xue Za Zhi, 84, 1678–1680. doi:10.5588/ijtld.10.0483
  • Lienhardt, C., Sillah, J., Fielding, K., Donkor, S., Manneh, K., Warndorff, D., … McAdam, K. (2003). Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics, 111( 5 Pt 1), e608–e614. doi:10.1542/peds.111.5.e608
  • Martinson, N. A., Moultrie, H., van Niekerk, R., Barry, G., Coovadia, A., Cotton, M., … Meyers, T. (2009). HAART and risk of tuberculosis in HIV-infected South African children: A multi-site retrospective cohort. The International Journal of Tuberculosis and Lung Disease, 13, 862–867.
  • Raviglione, M. C., Snider, D. E., Jr., & Kochi, A. (1995). Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. Journal of the American Medical Association, 273, 220–226. doi:10.1001/jama.1995.03520270054031
  • Sterling, T. R., Lau, B., Zhang, J., Freeman, A., Bosch, R. J., Brooks, J. T., & Moore, R. D. (2011). Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: Implications for tuberculosis screening. Journal of Infectious Diseases, 204, 893–901. doi:10.1093/infdis/jir421
  • USCDC. (2009). Morbidity and Mortality Weekly Report. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. Washington, DC: U.S. Government Printing Office (GPO).
  • Van Rossum, A. M., Fraaij, P. L., & de, G. R. (2002). Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infectious Diseases, 2, 93–102. doi:10.1016/S1473-3099(02)00183-4
  • Walters, E., Cotton, M. F., Rabie, H., Schaaf, H. S., Walters, L. O., & Marais, B. J. (2008). Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatrics, 8, 1. doi:10.1186/1471-2431-8-1
  • World Health Organization. (2006a). Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: WHO Press.
  • World Health Organization. (2006b). Management of tuberculosis and HIV coinfection. Clinical protocol for the WHO European region. Geneva: WHO Press.
  • World Health Organization. (2008). A revised framework to address TB-HIV co-infection in the Western Pacific region. Geneva: WHO Press.
  • World Health Organization. (2010a). Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. Geneva: WHO Press.
  • World Health Organization. (2010b). Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIV-infected children: Recommendations for a public health approach. Geneva: WHO Press.
  • World Health Organization. (2010c). Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2010 revision. Geneva: Author. Retrieved from http://www.who.int/hiv/pub/arv/adult2010/en/index.html
  • World Health Organization. (2011). TB/HIV FACTS 2011. WHO report. Geneva: WHO Press.
  • World Health Organization. (2012). Global Tuberculosis Control. Geneva: WHO Press.
  • Zampoli, M., Kilborn, T., & Eley, B. (2007). Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. The International Journal of Tuberculosis and Lung Disease, 11, 417–423.
  • Zhang, F., Au, M. C., Bouey, P. D., Zhao, Y., Huang, Z. J., Dou, Z., … Yu, L. (2007). The diagnosis and treatment of HIV-infected children in China: Challenges and opportunities. Journal of Acquired Immune Deficiency Syndromes, 44, 429–434. doi:10.1097/QAI.0b013e31803133ac
  • Zhang, F., Dou, Z., Ma, Y., Zhang, Y., Zhao, Y., Zhao, D., … Chen, R. Y. (2011). Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: A national observational cohort study. Lancet Infectious Disease, 11, 516–524. doi:10.1016/S1473-3099(11)70097-4
  • Zhang, F., Haberer, J., Wei, H., Wang, N., Chu, A., Zhao, Y., & Zhao, H. (2009). Drug resistance in the Chinese National Pediatric highly active antiretroviral therapy cohort: Implications for paediatric treatment in the developing world. International Journal of STD and AIDS, 20, 406–409. doi:10.1258/ijsa.2008.008357
  • Zhang, F., Haberer, J. E., Zhao, Y., Dou, Z., Zhao, H., He, Y., & Cao, G. H. (2007). Chinese pediatric highly active antiretroviral therapy observational cohort: A 1-year analysis of clinical, immunologic, and virologic outcomes. Journal of Acquired Immune Deficiency Syndromes, 46, 594–598. doi:10.1097/QAI.0b013e318158c08e
  • Zhao, Y., Li, C., Sun, X., Mu, W., McGoogan, J. M., He, Y., … Zhang, F. (2012). Mortality and treatment outcomes of China's National pediatric antiretroviral therapy program. Clinical Infectious Disease, 56, 735–744.
  • Zhao, Y., Mu, W., Harwell, J., Zhou, H., Sun, X., Cheng, Y., … Zhang, F. (2011). Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: An observational cohort study in rural China. Journal of Acquired Immune Deficiency Syndromes, 58, 47–53. doi:10.1097/QAI.0b013e318229f2a2
  • Zhao, Y., Sun, X., He, Y., Tang, Z., Peng, G., Liu, A., … Zhang, F. (2010). Progress of the National Pediatric Free Antiretroviral Therapy program in China. AIDS Care, 22, 1182–1188. doi:10.1080/09540121003615129
  • Zhang, Y., Sun, K., Yu, L., Tang, Z., Huang, S., Meng, Z., … Zhang, F. (2012). Factors associated with survival among adults with HIV-associated TB in Guangxi, China: A retrospective cohort study. Future Virology, 7, 933–942. doi:10.2217/fvl.12.76

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.